These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 841947)

  • 1. [Use of bifidumbacterin in young children with acute intestinal diseases].
    Protoklitova NS; Sterligova ND; Naumova MA; Romanov MV
    Vopr Okhr Materin Det; 1977; 22(2):54-8. PubMed ID: 841947
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of bifidumbacterin in the prevention of mastitis].
    Sytnik SI; Panichev VA; Dautov AG
    Vrach Delo; 1990 Mar; (3):98-100. PubMed ID: 2368375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in the use of bifidumbacterin in children with prolonged intestinal diseases].
    Zatsepin IuK; D'iakova EI; Goncharova GI; Liannaia AM; Kozlova EP; Aleksandrova AM; Kozhevitskaia OB
    Pediatriia; 1970 May; 49(5):62-4. PubMed ID: 5447911
    [No Abstract]   [Full Text] [Related]  

  • 4. [New Soviet preparation, dry bifidobacterin, and its effectiveness in intestinal diseases in children].
    Goncharova GI; Kozlova EP; Liannaia AM; Zatsepin IuK
    Pediatr Akus Ginekol; 1974; (4):22-3. PubMed ID: 4463318
    [No Abstract]   [Full Text] [Related]  

  • 5. [A trial of using a dry bifidobacterin preparation with newborn risk groups to prevent acute intestinal infections].
    Chernysheva NA; Mel'nikova KI; Finkel' MP; Izotova ZB
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):37-9. PubMed ID: 8017124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the effectiveness of biological antagonist preparations in intestinal infections in children].
    Avanesova AG; Lazareva NA; Ruzaikina NI; D'iakova EI; Kurnosova NA
    Vopr Okhr Materin Det; 1973 Jul; 18(7):39-43. PubMed ID: 4762308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adequate therapy of intestinal dysbacteriosis in children].
    Bel'mer SV; Gasilina TV
    Klin Med (Mosk); 1998; 76(10):35-8. PubMed ID: 9865015
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy of using bifidokefir for the treatment of acute intestinal infections and for the correction of dysbacterosis in children].
    Murashova AO; Novokshonov AA; Uchaĭkin VF
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):108-10. PubMed ID: 7879497
    [No Abstract]   [Full Text] [Related]  

  • 9. [A method for assessing the efficacy of using bifidumbacterin for the prevention of suppurative-inflammatory diseases in the newborn].
    Cherniatina LF; Berezhnoĭ VF; Tulupova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):36-40. PubMed ID: 2385987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal microbiocensosis and immune status in young children with severe forms of acute pneumonia after the use of different therapy regimens].
    Dolgushin II; Ogoshkova IA; Rusanova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (3):69-73. PubMed ID: 9700889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of colibacterin in children with dysentery and in some other intestinal infections].
    Riabinskaia TF; Kanshina OA; D'iakova EI; Koroleva AI
    Vopr Okhr Materin Det; 1967 Jun; 12(7):89-90. PubMed ID: 4887098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement].
    Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA
    Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correction of intestinal dysbacteriosis in elderly patients with the use of bifidobacterin introduced by different routes].
    Chulok TA; Kaverina KG; Shumova SL; Matsulevich TV; Doroshenko EO
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):76-8. PubMed ID: 15188566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiology of acute enteric infection in children with arid zone and effect of probiotics].
    Utemuradova GE
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):98-100. PubMed ID: 19623719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intestinal dysbacteriosis in children].
    Iatsyk GV; Gribakin SG
    Feldsher Akush; 1988 Mar; 53(3):36-9. PubMed ID: 3378637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of bifidumbacterin for prevention of staphylococcal infections in newborn infants].
    Astakhov II
    Vopr Okhr Materin Det; 1978 Jan; 23(1):75-7. PubMed ID: 625915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment efficacy in acute intestinal infections, chronic diseases of the gastrointestinal tract and viral hepatitis B using large doses of Russian Bifidumbacterin-forte].
    Gracheva NM; Shcherbakov IT; Avakov AA; Matsulevich TV
    Voen Med Zh; 1999 May; 320(5):51-7, 96. PubMed ID: 10401251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impaired interferon status in children with acute respiratory infection and its correction with bifidumbacterin-forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Murashova AO
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):65-7. PubMed ID: 11548264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.